VOYA Q1 2026 Earnings Earnings Beat Driven by Strong Underwriting and Asset Growth Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances AKTS Q1 2026 Earnings ClinicalStage Biotech Posts WiderThanExpected Loss Shares Edge Higher CIG Q1 2026 Earnings EPS Beats Estimates by 1247 Shares Edge Lower Heritage Financial Corporation Q1 2026 Earnings EPS Beats Estimates by 343 Amid Steady Operations Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline Melar Acquisition Corp I Warrants MACIW Hold Steady Near Support After Minor Decline SciSparc Ltd SPRC Gains 207 in Light Trading Key Support Holds Above 400 GCM Grosvenor GCMG Slips Slightly as Resistance Caps NearTerm Upside Okta Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Execution